
Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity
Keywords: Benzenesulfonamide; Thiazolidin-4-one; Carbonic anhydrase IX; Anticancer; Cell lines; Daltion's lymphoma ascitesCA, carbonic anhydrase; HIF-1, hypoxia-inducible transcription factor-1; DLA, Dalton's lymphoma ascites; DCC, N,N-dicyclohexylcarbodiimide; MTT